

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular potassium ion homeostasis (GO:0030007) | 5.78814862 |
| 2 | sodium ion export (GO:0071436) | 5.39515498 |
| 3 | amino sugar catabolic process (GO:0046348) | 5.29531136 |
| 4 | cerebellar granule cell differentiation (GO:0021707) | 5.08637729 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.08054688 |
| 6 | positive regulation of viral genome replication (GO:0045070) | 5.00916096 |
| 7 | postsynaptic membrane organization (GO:0001941) | 4.83537744 |
| 8 | N-acetylneuraminate metabolic process (GO:0006054) | 4.77245900 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 4.53916569 |
| 10 | fructose metabolic process (GO:0006000) | 4.52414109 |
| 11 | synaptic vesicle maturation (GO:0016188) | 4.46904156 |
| 12 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.37780457 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.36941476 |
| 14 | lung-associated mesenchyme development (GO:0060484) | 4.34007596 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.32933418 |
| 16 | vocalization behavior (GO:0071625) | 4.27446093 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.26990723 |
| 18 | locomotory exploration behavior (GO:0035641) | 4.22074668 |
| 19 | neuromuscular process controlling posture (GO:0050884) | 4.17694936 |
| 20 | ADP metabolic process (GO:0046031) | 4.11460920 |
| 21 | positive regulation of membrane potential (GO:0045838) | 4.08523752 |
| 22 | amino acid import (GO:0043090) | 4.08387046 |
| 23 | potassium ion homeostasis (GO:0055075) | 4.07138223 |
| 24 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.06451916 |
| 25 | cell migration in hindbrain (GO:0021535) | 4.04894613 |
| 26 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.02388385 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 4.02352894 |
| 28 | potassium ion import (GO:0010107) | 4.00687539 |
| 29 | axon ensheathment in central nervous system (GO:0032291) | 3.95365340 |
| 30 | central nervous system myelination (GO:0022010) | 3.95365340 |
| 31 | glutamate secretion (GO:0014047) | 3.94068523 |
| 32 | purine nucleobase biosynthetic process (GO:0009113) | 3.93709270 |
| 33 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.91192357 |
| 34 | cell communication by electrical coupling (GO:0010644) | 3.88180652 |
| 35 | cellular sodium ion homeostasis (GO:0006883) | 3.86969680 |
| 36 | layer formation in cerebral cortex (GO:0021819) | 3.83653259 |
| 37 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.82640224 |
| 38 | auditory behavior (GO:0031223) | 3.80362747 |
| 39 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.77861573 |
| 40 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.77742171 |
| 41 | synaptic transmission, glutamatergic (GO:0035249) | 3.77033005 |
| 42 | neuronal ion channel clustering (GO:0045161) | 3.76665220 |
| 43 | nucleobase biosynthetic process (GO:0046112) | 3.72972152 |
| 44 | regulation of neurotransmitter secretion (GO:0046928) | 3.70140258 |
| 45 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.70004387 |
| 46 | regulation of synapse maturation (GO:0090128) | 3.67021634 |
| 47 | neuron-neuron synaptic transmission (GO:0007270) | 3.66531771 |
| 48 | protein localization to synapse (GO:0035418) | 3.64808672 |
| 49 | synaptic vesicle endocytosis (GO:0048488) | 3.56055892 |
| 50 | chaperone-mediated protein transport (GO:0072321) | 3.55432236 |
| 51 | glutamate receptor signaling pathway (GO:0007215) | 3.54691984 |
| 52 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.53634648 |
| 53 | neurotransmitter secretion (GO:0007269) | 3.52181801 |
| 54 | L-amino acid import (GO:0043092) | 3.51413442 |
| 55 | regulation of DNA methylation (GO:0044030) | 3.51359507 |
| 56 | positive regulation of dendritic spine development (GO:0060999) | 3.43647890 |
| 57 | C4-dicarboxylate transport (GO:0015740) | 3.39064947 |
| 58 | membrane depolarization (GO:0051899) | 3.38995469 |
| 59 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.38581697 |
| 60 | regulation of neurotransmitter transport (GO:0051588) | 3.38015793 |
| 61 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.36324006 |
| 62 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.35967635 |
| 63 | mechanosensory behavior (GO:0007638) | 3.35556339 |
| 64 | regulation of ARF protein signal transduction (GO:0032012) | 3.35093040 |
| 65 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.32188747 |
| 66 | gamma-aminobutyric acid transport (GO:0015812) | 3.32021854 |
| 67 | response to auditory stimulus (GO:0010996) | 3.31492595 |
| 68 | exploration behavior (GO:0035640) | 3.27680379 |
| 69 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.25284362 |
| 70 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.24745352 |
| 71 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.23695044 |
| 72 | otic vesicle formation (GO:0030916) | 3.22570468 |
| 73 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.21592466 |
| 74 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.21405124 |
| 75 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.20169328 |
| 76 | proline transport (GO:0015824) | 3.14999494 |
| 77 | neuromuscular synaptic transmission (GO:0007274) | 3.14991224 |
| 78 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.12362456 |
| 79 | keratinocyte development (GO:0003334) | 3.11892528 |
| 80 | cell communication involved in cardiac conduction (GO:0086065) | 3.10920847 |
| 81 | neuromuscular process (GO:0050905) | 3.10906455 |
| 82 | neurotransmitter transport (GO:0006836) | 3.09867492 |
| 83 | regulation of synaptic vesicle transport (GO:1902803) | 3.09737479 |
| 84 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.06332900 |
| 85 | termination of RNA polymerase I transcription (GO:0006363) | 3.06332856 |
| 86 | innervation (GO:0060384) | 3.05194010 |
| 87 | long-term memory (GO:0007616) | 3.04155496 |
| 88 | adult walking behavior (GO:0007628) | 3.04023450 |
| 89 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.00993109 |
| 90 | synaptic transmission (GO:0007268) | 3.00750141 |
| 91 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.00440680 |
| 92 | regulation of synaptic transmission (GO:0050804) | 2.97772007 |
| 93 | dendrite morphogenesis (GO:0048813) | 2.97405464 |
| 94 | regulation of dendritic spine development (GO:0060998) | 2.97147678 |
| 95 | positive regulation of neurotransmitter transport (GO:0051590) | 2.95482134 |
| 96 | regulation of synapse structural plasticity (GO:0051823) | 2.93933786 |
| 97 | dendritic spine morphogenesis (GO:0060997) | 2.90633023 |
| 98 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.89052751 |
| 99 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.89052751 |
| 100 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.88760347 |
| 101 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.87279933 |
| 102 | regulation of neurotransmitter levels (GO:0001505) | 2.86284592 |
| 103 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.84794548 |
| 104 | neurotransmitter uptake (GO:0001504) | 2.84406900 |
| 105 | neuron recognition (GO:0008038) | 2.83939758 |
| 106 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.83718409 |
| 107 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.83621358 |
| 108 | regulation of collateral sprouting (GO:0048670) | 2.83073330 |
| 109 | axonal fasciculation (GO:0007413) | 2.82317945 |
| 110 | cullin deneddylation (GO:0010388) | 2.81146036 |
| 111 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.80906443 |
| 112 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.80185499 |
| 113 | transmission of nerve impulse (GO:0019226) | 2.78604725 |
| 114 | presynaptic membrane assembly (GO:0097105) | 2.78111493 |
| 115 | acidic amino acid transport (GO:0015800) | 2.77896994 |
| 116 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.77809630 |
| 117 | determination of adult lifespan (GO:0008340) | 2.77440746 |
| 118 | behavioral fear response (GO:0001662) | 2.76333872 |
| 119 | behavioral defense response (GO:0002209) | 2.76333872 |
| 120 | chemosensory behavior (GO:0007635) | 2.74192148 |
| 121 | neuromuscular process controlling balance (GO:0050885) | 2.73334759 |
| 122 | L-glutamate transport (GO:0015813) | 2.73312292 |
| 123 | positive regulation of synapse maturation (GO:0090129) | 2.70675390 |
| 124 | cell differentiation in hindbrain (GO:0021533) | 2.70492782 |
| 125 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.70168161 |
| 126 | autophagic vacuole assembly (GO:0000045) | 2.69757401 |
| 127 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.69662666 |
| 128 | presynaptic membrane organization (GO:0097090) | 2.68991539 |
| 129 | regulation of postsynaptic membrane potential (GO:0060078) | 2.67206099 |
| 130 | blastocyst development (GO:0001824) | 2.66022736 |
| 131 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.65994136 |
| 132 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.64582012 |
| 133 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 2.64304325 |
| 134 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.64064091 |
| 135 | membrane hyperpolarization (GO:0060081) | 2.64015769 |
| 136 | rRNA modification (GO:0000154) | 2.63670854 |
| 137 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.62399389 |
| 138 | membrane depolarization during action potential (GO:0086010) | 2.61986077 |
| 139 | fear response (GO:0042596) | 2.56588659 |
| 140 | regulation of synaptic plasticity (GO:0048167) | 2.54721264 |
| 141 | transcription from RNA polymerase I promoter (GO:0006360) | 2.53893237 |
| 142 | regulation of vesicle fusion (GO:0031338) | 2.53594029 |
| 143 | long-term synaptic potentiation (GO:0060291) | 2.53537251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.62473964 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.59852990 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.61304560 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.27567092 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.75559159 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.59996871 |
| 7 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.45437604 |
| 8 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.41448462 |
| 9 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.33365147 |
| 10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.28626046 |
| 11 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17539677 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.15623207 |
| 13 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13908061 |
| 14 | * TAF15_26573619_Chip-Seq_HEK293_Human | 2.13710942 |
| 15 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.12786855 |
| 16 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.06597647 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.00870402 |
| 18 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.00800138 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.94469403 |
| 20 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.94175389 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.93603537 |
| 22 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.88599834 |
| 23 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.86727658 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.83046523 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.79188433 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.72735134 |
| 27 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.71917874 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.63197004 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63101652 |
| 30 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62805552 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.61004537 |
| 32 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.60529554 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.59886274 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.59486787 |
| 35 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58345536 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.54739980 |
| 37 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.54715531 |
| 38 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53693652 |
| 39 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.51768492 |
| 40 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.50888189 |
| 41 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.50449844 |
| 42 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48458355 |
| 43 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.48390268 |
| 44 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.47579158 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.45348155 |
| 46 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.44880821 |
| 47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.44823143 |
| 48 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.41954926 |
| 49 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.40128661 |
| 50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.37902267 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37488173 |
| 52 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.36722782 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.35733111 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.35733111 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35043106 |
| 56 | * AR_19668381_ChIP-Seq_PC3_Human | 1.34881241 |
| 57 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.33197733 |
| 58 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.32735605 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32499627 |
| 60 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32274759 |
| 61 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.31313870 |
| 62 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.30344973 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30090899 |
| 64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29321017 |
| 65 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.29192258 |
| 66 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.28373590 |
| 67 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.28324368 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27563876 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26488640 |
| 70 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.24979789 |
| 71 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.23271418 |
| 72 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.22259693 |
| 73 | FUS_26573619_Chip-Seq_HEK293_Human | 1.22028125 |
| 74 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20675443 |
| 75 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.19654421 |
| 76 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.18718915 |
| 77 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.18381370 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17718045 |
| 79 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17019817 |
| 80 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.16481747 |
| 81 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.16473931 |
| 82 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.15997005 |
| 83 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.15940131 |
| 84 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.15647527 |
| 85 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15483929 |
| 86 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15438357 |
| 87 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14886915 |
| 88 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14366828 |
| 89 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.14125638 |
| 90 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.11987053 |
| 91 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11969071 |
| 92 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11594494 |
| 93 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10805743 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10216982 |
| 95 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.09790787 |
| 96 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09301960 |
| 97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09179919 |
| 98 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.08994042 |
| 99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08927507 |
| 100 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08899700 |
| 101 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08797013 |
| 102 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08626563 |
| 103 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08626563 |
| 104 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07562682 |
| 105 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07522446 |
| 106 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.06585683 |
| 107 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06503127 |
| 108 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06310568 |
| 109 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05770846 |
| 110 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.05192442 |
| 111 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04826334 |
| 112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04506127 |
| 113 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.04272394 |
| 114 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.03901339 |
| 115 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02885136 |
| 116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02154517 |
| 117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01532613 |
| 118 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.01425306 |
| 119 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01244726 |
| 120 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00801993 |
| 121 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.00738859 |
| 122 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00202738 |
| 123 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99880551 |
| 124 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99804258 |
| 125 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99616146 |
| 126 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98491962 |
| 127 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97150159 |
| 128 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97059659 |
| 129 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96935333 |
| 130 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96281792 |
| 131 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.96164996 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95748218 |
| 133 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94330069 |
| 134 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.94296209 |
| 135 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93666962 |
| 136 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93395589 |
| 137 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.92984336 |
| 138 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.92616165 |
| 139 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.92460430 |
| 140 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91707073 |
| 141 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91401843 |
| 142 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.91371596 |
| 143 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91066843 |
| 144 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.90919252 |
| 145 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90785780 |
| 146 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90530286 |
| 147 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.89951594 |
| 148 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.89858941 |
| 149 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89240180 |
| 150 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89213652 |
| 151 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.88999442 |
| 152 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88169666 |
| 153 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86942484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.25002690 |
| 2 | MP0003880_abnormal_central_pattern | 5.06944493 |
| 3 | MP0008260_abnormal_autophagy | 3.95945709 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.83619328 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.44857416 |
| 6 | MP0004270_analgesia | 3.14357652 |
| 7 | MP0009745_abnormal_behavioral_response | 2.97627068 |
| 8 | * MP0002064_seizures | 2.91957122 |
| 9 | MP0009046_muscle_twitch | 2.91082979 |
| 10 | MP0002822_catalepsy | 2.77421809 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.67016471 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.56031404 |
| 13 | MP0002272_abnormal_nervous_system | 2.41443327 |
| 14 | MP0001440_abnormal_grooming_behavior | 2.39436234 |
| 15 | MP0003718_maternal_effect | 2.30810408 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.26690855 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.16550794 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.13673410 |
| 19 | MP0006292_abnormal_olfactory_placode | 2.12834493 |
| 20 | MP0002736_abnormal_nociception_after | 2.09451794 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.06614563 |
| 22 | MP0001486_abnormal_startle_reflex | 2.06521605 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.03293360 |
| 24 | MP0004957_abnormal_blastocyst_morpholog | 1.92569758 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.84911241 |
| 26 | MP0001501_abnormal_sleep_pattern | 1.78643446 |
| 27 | MP0004885_abnormal_endolymph | 1.78034534 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.75156651 |
| 29 | MP0001970_abnormal_pain_threshold | 1.74693909 |
| 30 | MP0003693_abnormal_embryo_hatching | 1.67501195 |
| 31 | * MP0008569_lethality_at_weaning | 1.65675213 |
| 32 | MP0004142_abnormal_muscle_tone | 1.65642026 |
| 33 | MP0000778_abnormal_nervous_system | 1.65560965 |
| 34 | MP0003329_amyloid_beta_deposits | 1.61302547 |
| 35 | MP0003122_maternal_imprinting | 1.55458654 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.47609241 |
| 37 | MP0001502_abnormal_circadian_rhythm | 1.47320364 |
| 38 | MP0004924_abnormal_behavior | 1.45521183 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.45521183 |
| 40 | MP0003111_abnormal_nucleus_morphology | 1.44268815 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.42404361 |
| 42 | MP0002184_abnormal_innervation | 1.39264799 |
| 43 | MP0002909_abnormal_adrenal_gland | 1.38915226 |
| 44 | MP0003123_paternal_imprinting | 1.37584122 |
| 45 | MP0001485_abnormal_pinna_reflex | 1.34303592 |
| 46 | MP0001529_abnormal_vocalization | 1.34175772 |
| 47 | * MP0002066_abnormal_motor_capabilities/c | 1.33201071 |
| 48 | MP0004742_abnormal_vestibular_system | 1.31347125 |
| 49 | MP0001905_abnormal_dopamine_level | 1.28099415 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.27595883 |
| 51 | MP0004145_abnormal_muscle_electrophysio | 1.26258837 |
| 52 | MP0003632_abnormal_nervous_system | 1.25446562 |
| 53 | MP0005409_darkened_coat_color | 1.23896110 |
| 54 | MP0000955_abnormal_spinal_cord | 1.23416111 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.22796605 |
| 56 | MP0008057_abnormal_DNA_replication | 1.19251622 |
| 57 | MP0003315_abnormal_perineum_morphology | 1.15093451 |
| 58 | MP0003950_abnormal_plasma_membrane | 1.14695354 |
| 59 | MP0003879_abnormal_hair_cell | 1.10779300 |
| 60 | MP0008058_abnormal_DNA_repair | 1.08458759 |
| 61 | * MP0002882_abnormal_neuron_morphology | 1.08199910 |
| 62 | MP0001188_hyperpigmentation | 1.07705188 |
| 63 | MP0002229_neurodegeneration | 1.06073677 |
| 64 | MP0001984_abnormal_olfaction | 1.05441713 |
| 65 | MP0003631_nervous_system_phenotype | 1.03612014 |
| 66 | MP0000569_abnormal_digit_pigmentation | 0.94440603 |
| 67 | MP0009697_abnormal_copulation | 0.92296369 |
| 68 | MP0001963_abnormal_hearing_physiology | 0.92145153 |
| 69 | MP0001542_abnormal_bone_strength | 0.91812586 |
| 70 | MP0003690_abnormal_glial_cell | 0.91651570 |
| 71 | * MP0000920_abnormal_myelination | 0.91516603 |
| 72 | MP0002152_abnormal_brain_morphology | 0.90040717 |
| 73 | MP0001299_abnormal_eye_distance/ | 0.89587372 |
| 74 | MP0008872_abnormal_physiological_respon | 0.88875852 |
| 75 | MP0010386_abnormal_urinary_bladder | 0.88503788 |
| 76 | MP0003633_abnormal_nervous_system | 0.88157819 |
| 77 | MP0003787_abnormal_imprinting | 0.86106865 |
| 78 | MP0001177_atelectasis | 0.86100872 |
| 79 | MP0003121_genomic_imprinting | 0.84096433 |
| 80 | MP0006035_abnormal_mitochondrial_morpho | 0.82680693 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 0.82211521 |
| 82 | MP0003861_abnormal_nervous_system | 0.82114568 |
| 83 | MP0004147_increased_porphyrin_level | 0.81179921 |
| 84 | MP0003283_abnormal_digestive_organ | 0.80683895 |
| 85 | * MP0003634_abnormal_glial_cell | 0.79886024 |
| 86 | MP0004043_abnormal_pH_regulation | 0.79231634 |
| 87 | MP0001346_abnormal_lacrimal_gland | 0.78709361 |
| 88 | MP0005395_other_phenotype | 0.78002052 |
| 89 | MP0001348_abnormal_lacrimal_gland | 0.77064396 |
| 90 | MP0000579_abnormal_nail_morphology | 0.75679265 |
| 91 | MP0003077_abnormal_cell_cycle | 0.74363514 |
| 92 | MP0005646_abnormal_pituitary_gland | 0.74007490 |
| 93 | MP0002653_abnormal_ependyma_morphology | 0.72899282 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 0.72517846 |
| 95 | MP0005551_abnormal_eye_electrophysiolog | 0.71861292 |
| 96 | MP0006072_abnormal_retinal_apoptosis | 0.71616237 |
| 97 | MP0002069_abnormal_eating/drinking_beha | 0.70712046 |
| 98 | MP0004858_abnormal_nervous_system | 0.70092937 |
| 99 | * MP0010770_preweaning_lethality | 0.69994131 |
| 100 | * MP0002082_postnatal_lethality | 0.69994131 |
| 101 | MP0004215_abnormal_myocardial_fiber | 0.69469825 |
| 102 | MP0008874_decreased_physiological_sensi | 0.69106854 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.68937362 |
| 104 | MP0005645_abnormal_hypothalamus_physiol | 0.68783902 |
| 105 | MP0004085_abnormal_heartbeat | 0.67743858 |
| 106 | MP0004130_abnormal_muscle_cell | 0.67711966 |
| 107 | MP0000604_amyloidosis | 0.67679042 |
| 108 | MP0010094_abnormal_chromosome_stability | 0.67169491 |
| 109 | MP0002837_dystrophic_cardiac_calcinosis | 0.66642514 |
| 110 | MP0001943_abnormal_respiration | 0.65895298 |
| 111 | MP0008932_abnormal_embryonic_tissue | 0.64667609 |
| 112 | MP0002751_abnormal_autonomic_nervous | 0.63772841 |
| 113 | MP0005187_abnormal_penis_morphology | 0.62760059 |
| 114 | MP0002752_abnormal_somatic_nervous | 0.60002689 |
| 115 | MP0009780_abnormal_chondrocyte_physiolo | 0.59860023 |
| 116 | MP0001727_abnormal_embryo_implantation | 0.59825598 |
| 117 | MP0000372_irregular_coat_pigmentation | 0.58142043 |
| 118 | MP0002009_preneoplasia | 0.57900079 |
| 119 | * MP0010769_abnormal_survival | 0.57403721 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.56268654 |
| 121 | * MP0003956_abnormal_body_size | 0.55954101 |
| 122 | * MP0010768_mortality/aging | 0.55787080 |
| 123 | MP0005167_abnormal_blood-brain_barrier | 0.55419202 |
| 124 | MP0003136_yellow_coat_color | 0.55125255 |
| 125 | MP0003938_abnormal_ear_development | 0.54441814 |
| 126 | MP0003137_abnormal_impulse_conducting | 0.53918453 |
| 127 | MP0005535_abnormal_body_temperature | 0.53072234 |
| 128 | MP0002249_abnormal_larynx_morphology | 0.52920169 |
| 129 | * MP0002081_perinatal_lethality | 0.52704884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.90017634 |
| 2 | Myokymia (HP:0002411) | 5.68019061 |
| 3 | Hyperventilation (HP:0002883) | 4.58905750 |
| 4 | Focal seizures (HP:0007359) | 4.42478512 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.22076937 |
| 6 | Atonic seizures (HP:0010819) | 3.73820670 |
| 7 | Neurofibrillary tangles (HP:0002185) | 3.46968838 |
| 8 | Limb dystonia (HP:0002451) | 3.45510596 |
| 9 | Dialeptic seizures (HP:0011146) | 3.39535809 |
| 10 | Cerebral hypomyelination (HP:0006808) | 3.37467135 |
| 11 | Visual hallucinations (HP:0002367) | 3.37009606 |
| 12 | Abnormality of the labia minora (HP:0012880) | 3.36639440 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.29340058 |
| 14 | Absence seizures (HP:0002121) | 3.20533775 |
| 15 | Postural instability (HP:0002172) | 3.17520721 |
| 16 | Obstructive sleep apnea (HP:0002870) | 3.17307785 |
| 17 | Abnormality of the corticospinal tract (HP:0002492) | 3.12951553 |
| 18 | Papilledema (HP:0001085) | 3.12252029 |
| 19 | Febrile seizures (HP:0002373) | 3.09418910 |
| 20 | Oligodactyly (hands) (HP:0001180) | 3.07209659 |
| 21 | Action tremor (HP:0002345) | 2.99515552 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 2.99397765 |
| 23 | Broad-based gait (HP:0002136) | 2.97948308 |
| 24 | CNS hypomyelination (HP:0003429) | 2.95696467 |
| 25 | Annular pancreas (HP:0001734) | 2.95095137 |
| 26 | Septo-optic dysplasia (HP:0100842) | 2.85626425 |
| 27 | Status epilepticus (HP:0002133) | 2.84651735 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 2.84423066 |
| 29 | Absent speech (HP:0001344) | 2.83848460 |
| 30 | Hyperglycinemia (HP:0002154) | 2.82050634 |
| 31 | Delusions (HP:0000746) | 2.80757573 |
| 32 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.74505790 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 2.72676904 |
| 34 | Torticollis (HP:0000473) | 2.71806547 |
| 35 | Lower limb muscle weakness (HP:0007340) | 2.59886242 |
| 36 | Pheochromocytoma (HP:0002666) | 2.59531553 |
| 37 | Spastic gait (HP:0002064) | 2.59269142 |
| 38 | Dysmetric saccades (HP:0000641) | 2.58664616 |
| 39 | Ankle clonus (HP:0011448) | 2.52505364 |
| 40 | Abnormality of the lower motor neuron (HP:0002366) | 2.48171374 |
| 41 | Aplasia of the phalanges of the hand (HP:0009802) | 2.47385027 |
| 42 | Aplasia involving bones of the extremities (HP:0009825) | 2.47385027 |
| 43 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.47385027 |
| 44 | Akinesia (HP:0002304) | 2.44713733 |
| 45 | Maternal diabetes (HP:0009800) | 2.41905228 |
| 46 | Abnormal social behavior (HP:0012433) | 2.41025550 |
| 47 | Impaired social interactions (HP:0000735) | 2.41025550 |
| 48 | Rough bone trabeculation (HP:0100670) | 2.39065726 |
| 49 | Amblyopia (HP:0000646) | 2.38417811 |
| 50 | Epileptiform EEG discharges (HP:0011182) | 2.38152731 |
| 51 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.37900188 |
| 52 | Postnatal microcephaly (HP:0005484) | 2.36328180 |
| 53 | Sleep apnea (HP:0010535) | 2.34161142 |
| 54 | Impaired vibratory sensation (HP:0002495) | 2.32186876 |
| 55 | Poor eye contact (HP:0000817) | 2.31990785 |
| 56 | Bradykinesia (HP:0002067) | 2.30956745 |
| 57 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.30409169 |
| 58 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.30409169 |
| 59 | Insomnia (HP:0100785) | 2.29795643 |
| 60 | EEG with generalized epileptiform discharges (HP:0011198) | 2.27643411 |
| 61 | Dysmetria (HP:0001310) | 2.25348652 |
| 62 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.25128885 |
| 63 | Single umbilical artery (HP:0001195) | 2.25128885 |
| 64 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.25128885 |
| 65 | Anxiety (HP:0000739) | 2.24642370 |
| 66 | Stenosis of the external auditory canal (HP:0000402) | 2.23743945 |
| 67 | Neuroendocrine neoplasm (HP:0100634) | 2.22942883 |
| 68 | Megalencephaly (HP:0001355) | 2.19805473 |
| 69 | Hypsarrhythmia (HP:0002521) | 2.19675203 |
| 70 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.17509308 |
| 71 | Spinal muscular atrophy (HP:0007269) | 2.17387652 |
| 72 | Diplopia (HP:0000651) | 2.14702395 |
| 73 | Abnormality of binocular vision (HP:0011514) | 2.14702395 |
| 74 | Pancreatic fibrosis (HP:0100732) | 2.14435728 |
| 75 | Tongue fasciculations (HP:0001308) | 2.13059708 |
| 76 | Abnormal eating behavior (HP:0100738) | 2.12258633 |
| 77 | Peripheral hypomyelination (HP:0007182) | 2.12206037 |
| 78 | Impaired smooth pursuit (HP:0007772) | 2.11798110 |
| 79 | Osteomalacia (HP:0002749) | 2.09899854 |
| 80 | Intention tremor (HP:0002080) | 2.09060913 |
| 81 | Truncal ataxia (HP:0002078) | 2.08329414 |
| 82 | Turricephaly (HP:0000262) | 2.07943949 |
| 83 | Neuronal loss in central nervous system (HP:0002529) | 2.07421671 |
| 84 | Abnormality of the anterior horn cell (HP:0006802) | 2.07112117 |
| 85 | Degeneration of anterior horn cells (HP:0002398) | 2.07112117 |
| 86 | Agnosia (HP:0010524) | 2.05126686 |
| 87 | Dysdiadochokinesis (HP:0002075) | 2.02883730 |
| 88 | Amyotrophic lateral sclerosis (HP:0007354) | 2.02417093 |
| 89 | Stereotypic behavior (HP:0000733) | 2.01145777 |
| 90 | Restlessness (HP:0000711) | 1.99566223 |
| 91 | Nasolacrimal duct obstruction (HP:0000579) | 1.98716579 |
| 92 | Spastic tetraparesis (HP:0001285) | 1.98115170 |
| 93 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.97722383 |
| 94 | Urinary urgency (HP:0000012) | 1.97674778 |
| 95 | Split foot (HP:0001839) | 1.94745556 |
| 96 | Increased circulating renin level (HP:0000848) | 1.93341679 |
| 97 | Hepatic necrosis (HP:0002605) | 1.92936829 |
| 98 | Supranuclear gaze palsy (HP:0000605) | 1.91792052 |
| 99 | Craniofacial dystonia (HP:0012179) | 1.91710611 |
| 100 | Tetraplegia (HP:0002445) | 1.90726944 |
| 101 | Scanning speech (HP:0002168) | 1.89370404 |
| 102 | Clonus (HP:0002169) | 1.89263945 |
| 103 | Carpal bone hypoplasia (HP:0001498) | 1.88925148 |
| 104 | Muscle fibrillation (HP:0010546) | 1.87439475 |
| 105 | Hemiparesis (HP:0001269) | 1.86929386 |
| 106 | Abnormality of saccadic eye movements (HP:0000570) | 1.84822534 |
| 107 | Abnormal hair whorl (HP:0010721) | 1.83647287 |
| 108 | Choreoathetosis (HP:0001266) | 1.83637031 |
| 109 | Hepatocellular necrosis (HP:0001404) | 1.83062665 |
| 110 | Dysautonomia (HP:0002459) | 1.82217535 |
| 111 | Unsteady gait (HP:0002317) | 1.82122349 |
| 112 | Abnormality of glycine metabolism (HP:0010895) | 1.80268834 |
| 113 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.80268834 |
| 114 | Generalized myoclonic seizures (HP:0002123) | 1.80227490 |
| 115 | Lower limb asymmetry (HP:0100559) | 1.78551000 |
| 116 | Absent septum pellucidum (HP:0001331) | 1.78464394 |
| 117 | Impulsivity (HP:0100710) | 1.77248562 |
| 118 | Mutism (HP:0002300) | 1.76720341 |
| 119 | Protruding tongue (HP:0010808) | 1.75822892 |
| 120 | Depression (HP:0000716) | 1.75706687 |
| 121 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.75078705 |
| 122 | Apathy (HP:0000741) | 1.74964553 |
| 123 | Rigidity (HP:0002063) | 1.73984950 |
| 124 | Gait ataxia (HP:0002066) | 1.73883337 |
| 125 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.73430089 |
| 126 | Bronchomalacia (HP:0002780) | 1.73213668 |
| 127 | Drooling (HP:0002307) | 1.73114534 |
| 128 | Excessive salivation (HP:0003781) | 1.73114534 |
| 129 | Genetic anticipation (HP:0003743) | 1.72922742 |
| 130 | Fair hair (HP:0002286) | 1.72766479 |
| 131 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.72212787 |
| 132 | Spastic paraplegia (HP:0001258) | 1.71952233 |
| 133 | Incomplete penetrance (HP:0003829) | 1.70911853 |
| 134 | Cutaneous finger syndactyly (HP:0010554) | 1.70840560 |
| 135 | Alacrima (HP:0000522) | 1.67310691 |
| 136 | Hemiplegia (HP:0002301) | 1.67308168 |
| 137 | Premature graying of hair (HP:0002216) | 1.65630670 |
| 138 | Focal dystonia (HP:0004373) | 1.64804918 |
| 139 | Abnormality of the salivary glands (HP:0010286) | 1.64572418 |
| 140 | Abnormality of the septum pellucidum (HP:0007375) | 1.64354730 |
| 141 | Irritability (HP:0000737) | 1.64132630 |
| 142 | Fetal akinesia sequence (HP:0001989) | 1.62361070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK1 | 4.38302914 |
| 2 | EPHA4 | 4.25739660 |
| 3 | ARAF | 3.88140367 |
| 4 | NTRK3 | 3.15614533 |
| 5 | PNCK | 2.78115984 |
| 6 | MAP3K12 | 2.69529947 |
| 7 | STK16 | 2.44240122 |
| 8 | TSSK6 | 2.44141430 |
| 9 | WEE1 | 2.25576350 |
| 10 | EIF2AK3 | 2.19280867 |
| 11 | NME1 | 2.17236458 |
| 12 | MAP3K4 | 2.10155366 |
| 13 | CASK | 1.96956071 |
| 14 | MARK1 | 1.96324349 |
| 15 | MINK1 | 1.87206532 |
| 16 | MAP2K7 | 1.81863375 |
| 17 | PRKD3 | 1.67508911 |
| 18 | TNIK | 1.65380297 |
| 19 | AKT3 | 1.64530594 |
| 20 | CCNB1 | 1.58366039 |
| 21 | PIM2 | 1.55778082 |
| 22 | MAP3K9 | 1.52672745 |
| 23 | NTRK1 | 1.52215383 |
| 24 | NTRK2 | 1.51968741 |
| 25 | MKNK1 | 1.49425446 |
| 26 | MKNK2 | 1.38958677 |
| 27 | BRAF | 1.38548746 |
| 28 | PLK3 | 1.36640136 |
| 29 | PRKCG | 1.30587973 |
| 30 | PRKCH | 1.28587179 |
| 31 | ALK | 1.28011994 |
| 32 | RIPK1 | 1.26413308 |
| 33 | EIF2AK1 | 1.21481327 |
| 34 | GRK5 | 1.16210647 |
| 35 | PLK2 | 1.14793578 |
| 36 | FGFR2 | 1.11392262 |
| 37 | OXSR1 | 1.05839993 |
| 38 | MAP2K4 | 1.05385140 |
| 39 | KSR2 | 1.04674078 |
| 40 | DAPK1 | 1.04187646 |
| 41 | RAF1 | 1.04167763 |
| 42 | CAMKK2 | 1.02955530 |
| 43 | MAPK13 | 1.01903568 |
| 44 | PINK1 | 1.00475365 |
| 45 | CAMK1G | 0.96599964 |
| 46 | RIPK4 | 0.96534304 |
| 47 | VRK1 | 0.96350310 |
| 48 | DAPK2 | 0.94811297 |
| 49 | CDK5 | 0.92127735 |
| 50 | CDK19 | 0.91062921 |
| 51 | FES | 0.90439341 |
| 52 | CAMKK1 | 0.87282682 |
| 53 | PKN1 | 0.86960526 |
| 54 | SGK223 | 0.84201893 |
| 55 | SGK494 | 0.84201893 |
| 56 | BUB1 | 0.83913441 |
| 57 | NUAK1 | 0.81853943 |
| 58 | PAK6 | 0.80833402 |
| 59 | CAMK4 | 0.80657617 |
| 60 | MARK2 | 0.80621962 |
| 61 | LATS2 | 0.80544404 |
| 62 | NEK6 | 0.80519777 |
| 63 | RET | 0.77954331 |
| 64 | CDK18 | 0.73352652 |
| 65 | MAPK12 | 0.71306152 |
| 66 | CDK14 | 0.69968581 |
| 67 | CDK15 | 0.69563037 |
| 68 | PRPF4B | 0.69415334 |
| 69 | STK38 | 0.69303528 |
| 70 | SGK2 | 0.69241366 |
| 71 | CAMK2B | 0.66144510 |
| 72 | PDGFRA | 0.64898851 |
| 73 | UHMK1 | 0.62674367 |
| 74 | BRSK1 | 0.61068076 |
| 75 | CAMK2A | 0.60220664 |
| 76 | PRKCE | 0.58139153 |
| 77 | BCR | 0.57678865 |
| 78 | CDK11A | 0.57358193 |
| 79 | WNK3 | 0.56332527 |
| 80 | CAMK1 | 0.56269633 |
| 81 | CAMK2G | 0.53554214 |
| 82 | PBK | 0.53545210 |
| 83 | PDK2 | 0.53534447 |
| 84 | PDK1 | 0.52985303 |
| 85 | PRKCI | 0.51549453 |
| 86 | AURKA | 0.50370859 |
| 87 | EEF2K | 0.50259885 |
| 88 | KSR1 | 0.49969985 |
| 89 | CSNK1E | 0.49808889 |
| 90 | PHKG1 | 0.49785820 |
| 91 | PHKG2 | 0.49785820 |
| 92 | PAK1 | 0.48782629 |
| 93 | SGK3 | 0.48033587 |
| 94 | PLK1 | 0.47639096 |
| 95 | PRKCZ | 0.47518191 |
| 96 | CAMK1D | 0.46076973 |
| 97 | ROCK2 | 0.45930545 |
| 98 | SRPK1 | 0.45875256 |
| 99 | STK11 | 0.44785694 |
| 100 | MAPKAPK5 | 0.44488752 |
| 101 | SIK2 | 0.44176960 |
| 102 | CSNK1D | 0.44101878 |
| 103 | MAPK10 | 0.42988112 |
| 104 | PRKDC | 0.42098762 |
| 105 | CSNK1G2 | 0.42064541 |
| 106 | PRKACB | 0.42035994 |
| 107 | WNK1 | 0.41399583 |
| 108 | BMPR2 | 0.41313097 |
| 109 | CSNK1A1 | 0.40911810 |
| 110 | DYRK1A | 0.40633798 |
| 111 | MAP3K13 | 0.38914131 |
| 112 | ICK | 0.38856906 |
| 113 | FYN | 0.38537882 |
| 114 | SGK1 | 0.38096404 |
| 115 | CDK3 | 0.37784520 |
| 116 | PRKACA | 0.37349191 |
| 117 | TYRO3 | 0.37329563 |
| 118 | PDPK1 | 0.37138522 |
| 119 | RPS6KA3 | 0.37100436 |
| 120 | CDK1 | 0.36844731 |
| 121 | CSNK1G3 | 0.36727324 |
| 122 | DMPK | 0.36583906 |
| 123 | GSK3B | 0.36097512 |
| 124 | INSRR | 0.35735669 |
| 125 | RPS6KA2 | 0.35074099 |
| 126 | RPS6KB1 | 0.34434148 |
| 127 | CDK2 | 0.33997153 |
| 128 | CAMK2D | 0.33533363 |
| 129 | PAK3 | 0.32988701 |
| 130 | MAPK8 | 0.32594278 |
| 131 | PRKCB | 0.32108325 |
| 132 | CSNK1A1L | 0.30252791 |
| 133 | ERBB2 | 0.30135372 |
| 134 | PRKG1 | 0.30002253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.76332722 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.57871832 |
| 3 | Regulation of autophagy_Homo sapiens_hsa04140 | 3.25654645 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.05603628 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83488197 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.40518463 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.38526561 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.30863002 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.15880177 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.15110286 |
| 11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.11816706 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.07046796 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.00236391 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.98159339 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.93567239 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.91716067 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.88593802 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.86659996 |
| 19 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.84695271 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74670142 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.52343583 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.49123196 |
| 23 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.48585429 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47785251 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.43675808 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.39535956 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.37267004 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.35864703 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.33909643 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.32195949 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21645056 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.18949907 |
| 33 | RNA transport_Homo sapiens_hsa03013 | 1.16805938 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.14971527 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.13865165 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.09465118 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 1.08435379 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07913906 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06175324 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.06023687 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04509960 |
| 42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03713357 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.03553974 |
| 44 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03478054 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03344102 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03269490 |
| 47 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.02520202 |
| 48 | Mismatch repair_Homo sapiens_hsa03430 | 1.02218137 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 1.01279441 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00577887 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00357945 |
| 52 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.99050634 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 0.98064186 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97994850 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97479915 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96629424 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93355275 |
| 58 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.93192406 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.91061326 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89646883 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86588562 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86257397 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86116884 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.84078936 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83166261 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82182006 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81825578 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80576458 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.77723239 |
| 70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75988642 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75388183 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75251230 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74088057 |
| 74 | Gap junction_Homo sapiens_hsa04540 | 0.73146474 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.71811486 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71784638 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70349908 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68571671 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67748958 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65996614 |
| 81 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.65335271 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65112997 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64639693 |
| 84 | Alcoholism_Homo sapiens_hsa05034 | 0.64272206 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63773353 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62870834 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61471932 |
| 88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61099149 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60588119 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60551763 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60483854 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60447016 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.58889161 |
| 94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58783288 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57317726 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.57198778 |
| 97 | Phototransduction_Homo sapiens_hsa04744 | 0.55605928 |
| 98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55368457 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55096227 |
| 100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55059068 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53646212 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52137358 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50843442 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49819969 |
| 105 | Ribosome_Homo sapiens_hsa03010 | 0.49286737 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47760965 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47630275 |
| 108 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47246367 |
| 109 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46019207 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42632402 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42405302 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41768291 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41704258 |
| 114 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40982039 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40863500 |
| 116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40815647 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40783180 |
| 118 | Axon guidance_Homo sapiens_hsa04360 | 0.39507071 |
| 119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38440158 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37995804 |
| 121 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37597251 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37126219 |
| 123 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36851336 |
| 124 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.36003905 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35430981 |
| 126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.34626737 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.34185580 |
| 128 | Spliceosome_Homo sapiens_hsa03040 | 0.33814442 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32490034 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31659121 |
| 131 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31459205 |
| 132 | Cell cycle_Homo sapiens_hsa04110 | 0.31293078 |
| 133 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30765698 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.30690318 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28988232 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28586254 |
| 137 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27047170 |
| 138 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26983303 |
| 139 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26751711 |
| 140 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26745844 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23344892 |
| 142 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23225920 |
| 143 | Histidine metabolism_Homo sapiens_hsa00340 | 0.23066533 |
| 144 | Mineral absorption_Homo sapiens_hsa04978 | 0.20921453 |
| 145 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20605583 |
| 146 | ABC transporters_Homo sapiens_hsa02010 | 0.20093505 |

